Abstract:Objective To study the clinical significance on the combined determination of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP),heart-type fatty acid-binding protein(H-FABP)and cardiac troponin I(cTnI)in elder patients with severe heart failure (HF ).Methods The serum NT-proBNP,H-FABP and cTnI levels were determined in 31 2 elder patients with severe HF {main adverse cardiovascular event (MACE )group (1 94 cases ) [cardiogenic readmission group(1 1 0 cases)and death group(84 cases)]and no-MACE group(1 1 8 cases)}on admission, day 7,1 5,30 and 60 after treatment,76 elder patients with no-severe HF and 40 elder healthy subjects.The MACE were followed and observed for 1 80 d.The significance of NT-proBNP,H-FABP and cTnI for the diagnosis of severe HF and the prediction of death risk was analyzed by receiver operating characteristic(ROC)curve.Survival analysis was performed by Kaplan-Meier curve.Results The serum NT-proBNP,H-FABP and cTnI levels in elder patients with severe HF were significantly higher than those in elder patients with no-severe HF and healthy subjects (P<0.01 ),the positive rate of H-FABP in elder patients with no-severe HF was 47.1%,and the positive rate of cTnI was 4.5%.The serum NT-proBNP levels were positively correlated with the grade of New York Heart Association (NYHA)Ⅰ-Ⅳ(r=0.77,P<0.01 ).The ROC curve indicated that the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for diagnosis in elder patients with severe HF were 4 601 .50 ng/L,5.1 6 ng/L and 0.025 ng/mL,and the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for the death risk evaluation in elder patients with severe HF were 8 1 78.50 ng/L, 1 1 .77ng/L and 0.038ng/mL,respectively.The sensitivity of the combined determination was obviously better than those of the individual determinations (P<0.05 ).Before the treatment,the serum NT-proBNP levels in MACE group were significantly higher than those in no-MACE group(P<0.05),the serum H-FABP levels in death group were significantly higher than those in no-death group(P<0.05 ),and the serum cTnI levels in various prognosis groups had no statistical significance (P>0.05 ).The serum NT-proBNP,H-FABP and cTnI levels in no-MACE group on day 7 after treatment were significantly lower than those before the treatment (P<0.05 ).The decreasing rates of the 3 parameters were >50%,and the serum H-FABP level was lower than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in the cardiogenic readmission group on day 1 5 after treatment were significantly lower than those before treatment (P<0.05),but the decreasing rates of the 3 parameters were <30%,and the serum H-FABP level was higher than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in death group on day 7 and day 30 after treatment were significantly higher than those before treatment(P<0.05),and the serum cTnI levels were higher than the normal reference value.Kaplan-Meier survival curve showed that the survival rates of serum NT-proBNP,H-FABP and cTnI levels had significant difference (P <0.05 ).Conclusions There is an important clinical significance of the combined determination of serum NT-proBNP,H-FABP and cTnI levels for the diagnosis,prognosis,death risk evaluation and curative effect survey in elder patients with severe HF.

The Research of Joint Detection of C-Reactive Protein,Fibrinogen and N-terminal Pro-brain Natri-uretic Peptide in Patients with Chronic Atrial Fibrillation Complicated by Possible Heart Failure

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Relationship between levels of IL-6,CRP,AngⅡ and atrial fibrillation in patients with chronic heart failure

The value of diagnosis and prognosis diagnostic on heart failure patients by joint detection with CTnI, hs-CRP and NT-ProBNP

E0356 the Research on Calcium Homeostasis Expression and Gene Transcription of Atrial Myocytes in Patients with Atrial Fibrillation

Correlation among levels of high sensitive C reactive protein,natriuretic peptide,endothelin-1 and nonvalvular atrial fibrillation

Levels and clinical significance of serum NT-proBNP, UA and hs-CRP in chronic heart failure

Effect of atrial fibrillation on plasma NT-proBNP in patients with different cardiac functions PAN

Comparison of heart function parameters and correlation between plasma brain natriuretic peptide levels in non valvular disease patients with atrial fibrillation

Correlation between heart rate variability and brain natriuretic peptide in patients with persistent atrial fibrillation

The Clinical Significance on the Combined Determination of NT-proBNP,H-FABP and Ctni in Elder Patients with Severe Heart Failure

Study of serum Inflammatory factors levels in senile patients with nonvalvular atrial fibrillation

An Analysis on Related Factors of Nonvalvular Atrial Fibrillation and Atrial Filrillation Thrombosis Former State

Correlation Between ACE2 ,ACE2 Antibody ,Ang-(1-7 ) and NT-proBNP in Patients with Chronic Heart Failure

Investigation of Circulating Fractalkine and its Receptor CX3CR1 Levels in Patients With Chronic Congestive Heart Failure

Determinants of N-terminal ProBNP Levels in Patients with Atrial Fibrillation and Preserved Left Ventricular Systolic Function

Levels of fibrinogen, D-Dimer and high-sensitivity C-reactive protein in serum of patients with coronary atherosclerotic heart disease

Clinical Data Analysis of Patients with Atrial Fibrillation and Heart Failure

[C-Reactive Protein and Non-Valvula Atrial Fibrillation Combining with Thrombosis].

Clinical research of plasma BCAAs level in patients with chronic congestive heart failure

Clinical Effects of Recombinant Human BNP in Treating Acute Heart Failure and Study on Its Effects on TWEAK and Nt-Pro BNP